SCHEMBL6566865

SCHEMBL6566865

COC(=O)c1cc(N)ccc1OC(c1ccc(F)cc1)c1ccc(F)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 4/20 0.46
ALDH1A1 P00352 6/20 0.42
HPGD P15428 4/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
SLC6A4 P31645 1/20 0.40
SLC6A3 Q01959 1/20 0.40
IKBKB O14920 1/20 0.39
KDM4E B2RXH2 4/20 0.38
MAPT P10636 3/20 0.38
HSD17B10 Q99714 3/20 0.38
TSHR P16473 2/20 0.38
ALOX15 P16050 1/20 0.38
ALOX5 P09917 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
NPC1 O15118 1/20 0.36
CASP3 P42574 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564586 0.95 SLC6A4 (0.42) GAAALDH1A1HPGDSMN1; SMN2SLC6A4
SCHEMBL6564439 0.94 ALDH1A1 (0.43) GAAALDH1A1HPGDSMN1; SMN2SLC6A4
SCHEMBL6564379 0.92 CFTR (0.47) GAAALDH1A1HPGDSMN1; SMN2KDM4E
SCHEMBL6566689 0.89 ALDH1A1 (0.40) GAAALDH1A1HPGDSMN1; SMN2SLC6A4
SCHEMBL6567992 0.89 SLC6A4 (0.39) GAAALDH1A1HPGDSMN1; SMN2SLC6A4
SCHEMBL6565793 0.87 CA12 (0.37) GAAALDH1A1HPGDSMN1; SMN2SLC6A3
SCHEMBL6567926 0.87 HPGD (0.42) GAAALDH1A1HPGDSMN1; SMN2SLC6A4
SCHEMBL6564533 0.86 GAA (0.48) GAAALDH1A1HPGDSMN1; SMN2SLC6A4
SCHEMBL6568096 0.86 IDO1 (0.33) GAAALDH1A1HPGDSMN1; SMN2ALOX5
SCHEMBL6565966 0.86 SMN1; SMN2 (0.45) GAAALDH1A1HPGDSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 GAA 3305/4885ALDH1A1 907/4885HPGD 557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.